YM-60828, a novel factor Xa inhibitor: Separation of its antithrombotic effects from its prolongation of bleeding time
- 1 November 1997
- journal article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 339 (2-3) , 141-146
- https://doi.org/10.1016/s0014-2999(97)01389-7
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Antithrombotic actions of argatroban in rat models of venous, ‘mixed’ and arterial thrombosis, and its effects on the tail transection bleeding timeBritish Journal of Pharmacology, 1994
- Direct thrombin inhibitors in cardiovascular medicine.Circulation, 1994
- Study of anticoagulant mechanism of low molecular weight heparinThrombosis Research, 1992
- Oral Anticoagulant DrugsNew England Journal of Medicine, 1991
- Evaluation of the inhibition by heparin and hirudin of coagulation activation during r-tPA-induced thrombolysisBlood, 1989
- Thrombin Interactions with Platelet Membrane ProteinsaAnnals of the New York Academy of Sciences, 1986
- The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbitsBlood, 1982
- Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragments in rabbitsThrombosis Research, 1982
- Molecular weight dependency of the heparin potentiated inhibition of thrombin and activated factor X. Effect of heparin neutralization in plasmaThrombosis Research, 1979
- Anticoagulant Action of HeparinNature, 1973